©2019 by ScientificMed Tech AB

Latest News

ScientificMed announces the appointment of two new board members Josefin Landgård and Martin Olovsson

October 8, 2019

ScientificMed strengthens leadership with the addition of two new Board Members, Josefin Landgård and Martin Olovsson, and the Senior Business Advisor Annika Espander.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed in collaboration with Karolinska Institutet in new stroke prevention research project

June 23, 2019

The HELD research group at Karolinska Institutet evaluates in a pilot study the feasibility and effect of a person-centered and digital stroke prevention program. ScientificMed is contracted to provide the e-health platform.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed has raised SEK 10 million in capital for continued development of digital cancer treatments

January 16, 2019

ScientificMed has successfully raised SEK 10 million in capital from Bonit Capital, Add Health Media, serial entrepreneur Fabian Fischer, and the ScientificMed founders. The capital will allow the company to increase development speed of its cancer treatment digitization products and accelerate its international growth.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed to take part in collaborative research project together with Karolinska Institutet

November 5, 2018

ScientificMed will participate in a research project funded by the Swedish innovation agency Vinnova and their program Challenge-Driven Innovation. Research will be done in collaboration with Karolinska Insitutet, Innovation Skåne, Region Skåne, Region Östergötland, and RISE (Research Institutes of Sweden).

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

Positive study results

October 8, 2018

Positive results from two minor studies: one of e-treatment supporting breast cancer patients in their treatments and well-being, the other one of e-treatment supporting patients with prevention for stroke.

In the evaluations, the patients regarded the e-treatments as easy to use, highly appreciated, and valuable. The patients wanted to continue using the e-treatments after the study’s completion. The positive results and feedback from the patients and healthcare personnel will be used during the next phase of the respective projects, including further development of the e-treatments and the implementation of broader usage in clinical practice.

For further information, please contact Johan Cederlund, ScientificMed, +46 708 63 60 05.

LSX Nordic Congress in Stockholm

June 10, 2018

ScientificMed will participate and present the company's e-treatment platform SciMedOne at the LSX Nordic Congress 2018 (Life Science Executives' Leadership and Investment Congress) in Stockholm, 29-30 August 2018.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed in collaboration with Karolinska Insititutet in stroke research project

December 15, 2017

The HELD research group at Karolinska Institutet develops and evaluates a patient-centered e-health program to support primary and secondary stroke prevention and rehabilitation after stroke. ScientificMed provides the e-health solution.

For further information, please contact Johan Cederlund, ScientificMed, +46 708 63 60 05.

The HealthyMoms clinical trial in collaboration with Karolinska Institutet

September 7, 2017

The HealthyMoms clinical trial (RCT) will evaluate whether a smartphone app can promote healthy gestational weight gain in pregnant women. ScientificMed works in collaboration with Karolinska Institutet as solution provider.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed to take part in oncology research project in collaboration with major healthcare provider

September 1, 2017

ScientificMed will in collaboration with a major Swedish healthcare provider and a specialist within oncology treatments develop and evaluate a patient centric application for patients diagnosed with breast cancer. The primary objectives are to improve the adherence to treatment and improve wellbeing of the patients. The overall aim of the project is to launch the e-treatment broadly within clinical practice, integrated into the infrastructure and processes of oncology care in Sweden.

For further information, please contact Johan Cederlund, ScientificMed, +46 708 63 60 05.

The positive results from the MINISTOP trial published in AJCN, The American Journal of Clinical Nutrition

April 26, 2017

he MINISTOP trial will be published in the upcoming edition of the American Journal of Clinical Nutrition.

This paper reports the first results of an mHealth obesity intervention targeting parents of preschoolaged children. Although no effect on the primary outcome fat mass index (FMI) was observed, children in the intervention group had 99% higher odds of increasing the composite score for the 6 dietary and physical activity variables.

Furthermore, the effect of the intervention was more pronounced in the children with a higher FMI. Given the young age of the children, MINISTOP focused on promoting a healthy diet and physical activity rather than weight management or energy restriction. The mHealth intervention was also highly accepted by parents with suitable levels of sustained engagement.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

View AJCN online

The SUPPORT trial published in AHJ, American Heart Journal

May 25, 2016

The SUPPORT trial will be published in the August edition of American Heart Journal.

Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study


In myocardial infarction patients, the use of an interactive patient support tool improved patient self-reported drug adherence and also showed trends toward improved cardiovascular lifestyle changes and quality of life.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

View AHJ online

Strong focus on prevention at European Society of Cardiology (ESC) Congress 2015 in London

September 10, 2015

“The topic of prevention was selected because of the increasing global presence of cardiovascular disease (CVD) and the therapeutic challenges this epidemic presents.”

“Among the clinical highlights of importance in the area of prevention is the SUPPORT trial involving patients with acute myocardial infarction being treated with ticagrelor. The study demonstrated the value of an interactive smartphone application in increasing drug adherence and adopting/continuing healthy cardiovascular lifestyle changes.” – Geneviève Derumeaux, ESC CPC Chair

View ESC Congress in Review

Positive results from the SUPPORT trial presented at the European Society of Cardiology (ESC) Congress 2015 in London

September 2, 2015

The use of a smartphone based motivational interactive patient support tool improved patient-registered drug adherence and showed positive trends in both cardiovascular-related lifestyle changes and quality of life in patients with acute myocardial infarction.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

Read the ESC Congress 2015 in Review here
AstraZeneca Press Release (in Swedish)

Data from the SUPPORT trial will be presented at the European Society of Cardiology (ESC) Congress 2015 in London

August 29, 2015

Data from the SUPPORT study demonstrating the impact of a new interactive smartphone application on improving patient adherence and quality of life will be explored during a rapid fire abstract session on Wednesday 2 September.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.

ScientificMed to take part in research project in collaboration with leading university and physicians

April 10, 2015

ScientificMed will in collaboration with physicians and a leading university, participate in a project financed by the Swedish innovation agency Vinnova. Key objectives are to develop and evaluate concrete patient values using CE-marked patient centric applications adapted to specific pharmaceutical products based on a firm business model and collaboration with pharmaceutical companies.

For further information, please contact Johan Cederlund, ScientificMed, +46 708 63 60 05.